Roche/Genentech Set Lower Rozlytrek Price To Catch Up With Bayer’s Vitrakvi

Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
Rozlytrek will compete with Vitrakvi for NTRK gene fusion patients. • Source: Shutterstock

More from New Products

More from Scrip